← All trials
NCT07261930
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2018
- Primary completion
- Feb 28, 2019
- Completion date
- May 1, 2019
- First posted
- Dec 3, 2025
- Last posted
- Dec 3, 2025
- Enrollment
- 43
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Masaka Regional Referral HospitalLead sponsor
- Makerere UniversityCollaborator
- Masaka Regional Referral HospitalOfficial
- Masaka Regional Referral HospitalSponsor investigator
- Mulago Hospital, UgandaCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.